|
Grant expands OU-COM research on Chagas disease
Training program aims to improve health of Ecuadoran
people
Elimination of
insect-borne
transmission of
Chagas disease is
one of the main
goals of the
program. |
(Athens, OH) A five-year, $750,000 National
Institutes of Health (NIH) grant will significantly expand research
efforts by the Ohio University College of Osteopathic Medicine
(OU-COM) into the transmission, diagnosis and treatment of Chagas
disease in Ecuador.
A potentially life-threatening illness caused by a
protozoan parasite spread by insects, blood transfusions and
congenially, Chagas disease is the focus of research by OU-COM and
its partner, the Center for Infectious Disease Research (CIDR) at
the
Pontificia Universidad Católica del Ecuador (PUCE) in
Quito.
Chagas affects 13 million people, mainly in the Americas.
Approximately 200,000 Ecuadorians are infected with Chagas.
Mario Grijalva, Ph.D., associate professor of
microbiology and director of the Tropical Disease Institute at the
Ohio University College of Osteopathic Medicine, said the grant will
be used to expand the Ecuadoran research training center. The Global
Infectious Diseases Training grant (GID) from the Fogarty
International Center at NIH will help researchers obtain biological
and clinical information to improve current Chagas disease control
efforts and implement a training program in infectious disease
research.
“Multidisciplinary research is going to be necessary
to improve Chagas disease control efforts in Ecuador,” said Grijalva.
“With this grant and together with
PUCE,
we can conduct that research. We also mean to substantially increase
the country’s research capacity with a training program that will
build a corps of infectious disease researchers and well-trained
technical personnel.”
Grijalva called Chagas disease a “neglected disease,”
since little action to prevent its transmission and limited research
about its treatment have occurred because it mainly affects
underserved populations, especially those living in poverty.
“Very little was known about Chagas disease in
Ecuador when I started doing research,” said Grijalva, originally
from Ecuador and who started researching Chagas disease in 1992. He
explained that there was lack of awareness about the disease because
researchers did not have the resources and skills necessary to study
the disease and advocate for policies and programs that would help
eradicate it.
“We hope to significantly improve the lives of
Ecuador citizens,” Grijalva said. “The training center will better
position scientists to act as effective public health policymakers
who can create the recommendations and programs that will stop the
spread of the disease and improve treatments.”
The program will be housed in a new 70,000 square
foot building that is currently under construction by PUCE (in
English, known as the Catholic University of Ecuador) on its new
campus near Quito. Slated to open in 2013, the facility will house
the labs and offices of 16 principal investigators, associated
staff, and research trainees currently located at CIDR, a joint
effort between OU-COM and PUCE first started in 1999.
The main hurdle to conducting meaningful research in
a developing country is the shortage of adequately trained
scientists, Grijalva said. Therefore, one of the main goals of the
Tropical Disease Institute in Ecuador has been to create the
institutional infrastructure that would allow highly competent
Ecuadorian researchers that have gotten advanced degrees to return
to Ecuador.

|
Jaime Costales, PhD
and Mario Grijalva,
PhD in a press
conference in Manabi,
Ecuador. |
“I was extremely pleased when Jaime A. Costales,
Ph.D., now an assistant professor of the CIDR, accepted a faculty
position at PUCE in 2008.”
Since his return to Ecuador, he has established his
own research program and collaborates with Grijalva on several
projects, including a major role in the preparation of the NIH
training grant.
“Jaime’s presence in Ecuador constitutes a critical
advance towards increasing the country’s research capacity. The GID
training grant will be a major vehicle to further these efforts,”
Grijalva said.
The NIH funding will support four post-doctoral
fellows who will join CIDR staff. The grant will also help implement
a master’s degree program at PUCE and provide funding for a student
from Ecuador to earn a Ph.D. from Ohio University.
The new program means expanded opportunities for
OU-COM medical students, faculty and researchers to travel to
Ecuador to provide clinical care and conduct research, Grijalva
said.
“This will increase the number of people available to
work with our students, increase the range of training and outreach
we can offer, and increase the number of services that we can
provide to help improve the health of the Ecuadoran people,”
Grijalva said.

|
Chagas disease
serological
screening in rural
areas of Ecuador |
Each year, Grijalva leads a team of more than 40
researchers, scientists and medical students, including several from
OU-COM, to study the disease in Ecuador. The World Health
Organization has cited this program as an example to develop a new
strategy for a global fight against the disease.
“I am thankful for this very prestigious award,”
Grijalva said of the grant. “It recognizes the work we have
accomplished in collaboration with Catholic University.”
|